Study of Mitomycin C and Nasal Splint to Treat Nasal Synechiae

This study has been completed.
Sponsor:
Information provided by:
Karnataka Institute of Medical Sciences
ClinicalTrials.gov Identifier:
NCT00966056
First received: August 25, 2009
Last updated: July 7, 2011
Last verified: August 2009
  Purpose

This study evaluates whether Mitomycin C is an effective alternative to septal splints in the treatment of nasal synechiae.


Condition Intervention Phase
Nasal Synechiae
Adhesions of Nasal Cavity
Nasal Adhesions
Tissue Adhesions
Drug: Mitomycin C
Device: Teflon nasal septal splint
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Comparative Study of Mitomycin C and Internal Nasal Septal Splint in the Treatment of Nasal Synechiae

Resource links provided by NLM:


Further study details as provided by Karnataka Institute of Medical Sciences:

Primary Outcome Measures:
  • Recurrence or absence of synechiae [ Time Frame: 1 week, 1 month, 2 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Symptoms and complications [ Time Frame: 1 week, 1 month, 2 months ] [ Designated as safety issue: Yes ]

Enrollment: 60
Study Start Date: October 2007
Study Completion Date: September 2009
Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Mitomycin C
Cases recruited into this arm receive topical application of mitomycin c (1mg/ml)following surgical synechiolysis
Drug: Mitomycin C
Cotton wick soaked with 1mg/ml of mitomycin c placed for 2 minutes between the raw surfaces after synechiolysis with surgical blade no.15
Other Name: Mitomycin, Mitocin, MMC
Active Comparator: Teflon septal splint
Cases recruited into this arm receive insertion of teflon internal nasal septal splint following surgical synechiolysis
Device: Teflon nasal septal splint
Teflon internal nasal septal splint placed between the raw surfaces and secured at the anterior end of septum with catgut 3-0 sutures, following synechiolysis with surgical blade no.15. Splint removed at the end of one week
Other Name: Teflon splint, nasal septal splint, internal nasal splint

Detailed Description:

Nasal synechiae is an important cause for the failure of many a nasal surgery. Septal splints have been widely used for the treatment of nasal synechiae, but are associated significant morbidity until removal. To the best of our knowledge there are no studies in literature comparing Mitomycin C with septal splints as an atraumatic alternative in the treatment of nasal synechiae. This is a preliminary study taken up to evaluate the therapeutic efficacy of Mitomycin C in the treatment of nasal synechiae.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patients with nasal mucosal synechiae due to surgical or non-surgical trauma

Exclusion Criteria:

  • Patients with nasal vestibular stenosis
  • Patients with nasal synechiae due to diseases like Hansen's disease, Syphilis, Rhinoscleroma, Atrophic Rhinitis etc.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00966056

Locations
India
Karnataka Institute of Medical Sciences
Hubli, Karnataka, India, 580022
Sponsors and Collaborators
Karnataka Institute of Medical Sciences
Investigators
Study Chair: VIKRAM K BHAT, MS(ENT), DNB Karnataka Institute of Medical Sciences
  More Information

No publications provided

Responsible Party: Dr SRINISH G, KARNATAKA INSTITUTE OF MEDICAL SCIENCES
ClinicalTrials.gov Identifier: NCT00966056     History of Changes
Other Study ID Numbers: 01_M012_3210
Study First Received: August 25, 2009
Last Updated: July 7, 2011
Health Authority: India: Institutional Review Board

Keywords provided by Karnataka Institute of Medical Sciences:
Nasal adhesions
Nasal synechiae
Mitomycin
Mitomycin c
Teflon
Splints
Septal splints

Additional relevant MeSH terms:
Tissue Adhesions
Cicatrix
Fibrosis
Pathologic Processes
Mitomycins
Mitomycin
Antibiotics, Antineoplastic
Antineoplastic Agents
Therapeutic Uses
Pharmacologic Actions
Alkylating Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Enzyme Inhibitors

ClinicalTrials.gov processed this record on September 30, 2014